Competing interests
obesity, enema
OBESITY, IRRITABLE BOWEL SYNDROME, SEVERE OBESITY, CLOSTRIDIOIDES DIFFICILE INFECTION
PHJ: North Norway Health trust - Personal fee as physician at dep. of internal medicine and researcher in a 50/50% position. South Eastern Norway Health Trust - Personal fee as researcher in a 20% position Principal investigator in REFIT 2 trial, An investigator-initiated and –run randomized trial investigating fecal microbiota transplantation by enema in patients with irritable bowel syndrome. PCV: Principal investigator in the study “Fecal microbiota transplantation in severe obesity”, The study is a RCT addressing FMT by enema in patients with severe obesity, initiated and run by the investigator and co-investigator. LCKS: The Research Council of Norway - Personal fee as a Ph.d. research fellow. Coordinating Investigator in the comeback study - An investigator-initiated and –run randomized trial investigating fecal microbiota transplantation by enema in patients with chronic fatigue syndrome/myalgic encephalomyelitis. Study co-worker in «the obesity study” - An investigator-initiated and –run randomized trial investigating fecal microbiota transplantation by enema in patients with severe obesity. Member scientific committee in the REFIT-2 trial - An investigator-initiated and –run randomized trial investigating fecal microbiota transplantation by enema in patients with irritable bowel syndrome. Member scientific committee in the C.O.L.O.N.I.Z.E trial - An investigator-initiated and –run randomized trial investigating fecal microbiota transplantation by enema versus oral vancomycin for primary Clostridioides difficile infection. HMH: Health Fund of Regional Health North Norway - Personal fee as a Ph.d. research fellow. Co-prinsipal investigator in “fecal microbiota transplantation in severe obesity” - A randomized controlled trial investigating fecal microbiota transplantation in patients with severe obesity. Subinvestigator in “fecal microbiota transplantation in CFS/ME” - An randomized controlled trial investigating fecal microbiota transplantation in patients with CFS/ME. Member scientific committee in REFIT2 trial - An investigator-initiated and –run randomized trial investigating fecal microbiota transplantation by enema in patients with irritable bowel syndrome. Member scientific committee in COLONIZE trial - An investigator-initiated and –run randomized trial investigating fecal microbiota transplantation by enema versus oral vancomycin for primary Clostridioides difficile infection. FEJ: South Eastern Norway Health Trust - Personal fee as a Ph.d. research fellow. Principal investigator in REFIT 2 trial - An investigator-initiated and –run randomized trial investigating fecal microbiota transplantation by enema in patients with irritable bowel syndrome. Co-Principal investigator in COLONIZE trial - An investigator-initiated and –run randomized trial investigating fecal microbiota transplantation by enema versus oral vancomycin for primary Clostridioides difficile infection.ØA: Non declared. RG: Non declared.